Correlation Between Scholastic and ArriVent BioPharma,

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Scholastic and ArriVent BioPharma, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Scholastic and ArriVent BioPharma, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Scholastic and ArriVent BioPharma, Common, you can compare the effects of market volatilities on Scholastic and ArriVent BioPharma, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Scholastic with a short position of ArriVent BioPharma,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Scholastic and ArriVent BioPharma,.

Diversification Opportunities for Scholastic and ArriVent BioPharma,

-0.67
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Scholastic and ArriVent is -0.67. Overlapping area represents the amount of risk that can be diversified away by holding Scholastic and ArriVent BioPharma, Common in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ArriVent BioPharma, and Scholastic is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Scholastic are associated (or correlated) with ArriVent BioPharma,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ArriVent BioPharma, has no effect on the direction of Scholastic i.e., Scholastic and ArriVent BioPharma, go up and down completely randomly.

Pair Corralation between Scholastic and ArriVent BioPharma,

Given the investment horizon of 90 days Scholastic is expected to generate 0.56 times more return on investment than ArriVent BioPharma,. However, Scholastic is 1.77 times less risky than ArriVent BioPharma,. It trades about -0.1 of its potential returns per unit of risk. ArriVent BioPharma, Common is currently generating about -0.27 per unit of risk. If you would invest  2,682  in Scholastic on September 13, 2024 and sell it today you would lose (138.00) from holding Scholastic or give up 5.15% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Scholastic  vs.  ArriVent BioPharma, Common

 Performance 
       Timeline  
Scholastic 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Scholastic has generated negative risk-adjusted returns adding no value to investors with long positions. Despite uncertain performance in the last few months, the Stock's technical indicators remain quite persistent which may send shares a bit higher in January 2025. The latest mess may also be a sign of long-standing up-swing for the company institutional investors.
ArriVent BioPharma, 

Risk-Adjusted Performance

7 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in ArriVent BioPharma, Common are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. Even with relatively weak fundamental drivers, ArriVent BioPharma, reported solid returns over the last few months and may actually be approaching a breakup point.

Scholastic and ArriVent BioPharma, Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Scholastic and ArriVent BioPharma,

The main advantage of trading using opposite Scholastic and ArriVent BioPharma, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Scholastic position performs unexpectedly, ArriVent BioPharma, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ArriVent BioPharma, will offset losses from the drop in ArriVent BioPharma,'s long position.
The idea behind Scholastic and ArriVent BioPharma, Common pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.

Other Complementary Tools

Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Equity Valuation
Check real value of public entities based on technical and fundamental data
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios